This resolution officially designates the first full week in May as "Tardive Dyskinesia Awareness Week." The measure highlights that Tardive Dyskinesia (TD) is a condition characterized by uncontrollable movements, often linked to prolonged antipsychotic medication use, and affects a significant number of individuals, many of whom remain undiagnosed. The resolution underscores the critical importance of early detection , intervention, and routine screening for TD, aligning with clinical guidelines from organizations like the American Psychiatric Association. It supports efforts to educate healthcare providers, patients, and caregivers about the causes, symptoms, and available treatments for TD. Ultimately, the Senate aims to improve care and quality of life for individuals living with or at risk of TD by promoting greater awareness and ensuring that patients prescribed antipsychotics receive comprehensive care, including regular screenings.